Evidence map›Paper›PMID 32784820›Full record

ArticleInternational journal of molecular sciences2020

The Cysteine-Rich Repeat Protein TaCRR1 Participates in Defense against Both

Feilong Guo, Zilong Shan, Jinfeng Yu, Gangbiao Xu, Zengyan Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Serine Rejuvenated DegeneratedJournal of fungi (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The Pathogen-Induced MATE GeneInternational journal of molecular sciences · 2022
    Article
  12. Blocked at the Stomatal Gate, a Key Step of WheatFrontiers in plant science · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Feilong GuoThe Laboratory of Forestry Genetics, Central South University of Forestry and Technology, Changsha 410004, China.
Zilong ShanShiJiaZhuang Academy of Agricultural and Forestry Sciences, Shijiazhuang 050041, China.
Jinfeng YuCollege of Plant Protection, Shandong Agricultural University, Taian 271018, China.
Gangbiao XuThe Laboratory of Forestry Genetics, Central South University of Forestry and Technology, Changsha 410004, China.
Zengyan ZhangThe National Key Facility for Crop Gene Resources and Genetic Improvement, Institute of Crop Science, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Chinese Academy of Agricultural Sciences · CNCentral South University · CNShandong Agricultural University · CNShijiazhuang Academy of Agriculture and Forestry Sciences · CN

Funding

National "Key Sci-Tech" Project 2016ZX08002-001-004
6 · The paper itself

Abstract

The domain of unknown function 26 (DUF26), harboring a conserved cysteine-rich motif (C-X8-C-X2-C), is unique to land plants. Several cysteine-rich repeat proteins (CRRs), belonging to DUF26-containing proteins, have been implicated in the defense against fungal pathogens in ginkgo, cotton, and maize. However, little is known about the functional roles of CRRs in the important staple crop wheat (

Indexed as

Gene Expression Regulation, PlantAmino Acid SequenceBipolarisDisease ResistancePhylogenyPlant DiseasesPlant ProteinsPlants, Genetically ModifiedRhizoctoniaSequence Homology, Amino AcidTriticumPlant Proteinsantifungal activityBipolaris sorokinianacysteine-rich repeat proteinDUF26 domainRhizoctonia cerealiswheat (Triticum aestivum)

Identifiers

PMID32784820
PMCPMC7461100
OpenAlexW3047948209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.